siRNA for inhibiting expression of CTGF gene, pharmaceutical composition containing siRNA and use of pharmaceutical composition
A gene expression and base technology, applied in the field of nucleic acid and pharmaceutical composition, can solve the problems of poor stability of siRNA activity, slow progress, slow progress of drugs, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0235] Example
[0236] Unless otherwise specified, the reagents and culture media used in the following examples are all commercially available products. The nucleic acid electrophoresis, real-time PCR and other operations used are all referred to the methods described in Molecular Cloning (Cold Spring Harbor Laboratory Press (1989)) get on.
[0237] Hela cells were provided by the Nucleic Acid Technology Laboratory of the Institute of Molecular Medicine, Peking University, with 20% fetal bovine serum (FBS, Hyclone) and 0.2% by volume penicillin double antibody (Penicillin-Streptomycin, Gibco, Invitrogen) Culture cells in complete DMEM medium (Hyclone) at 37℃ in 5% CO 2 / Cultivate in an incubator with 95% air.
[0238] If there is no other instructions, the reagent ratios provided below are calculated by volume ratio (v / v).
Example Embodiment
[0239] Preparation Example 1 Synthesis of siRNA sequence
[0240] In siRNA synthesis, unless otherwise specified, the nucleoside monomer refers to the modified nucleoside phosphoramidite used in the solid phase synthesis of phosphoramidites according to the type and sequence of nucleotides in the siRNA to be prepared Monomers (modified RNA phosphoramidites). Phosphoramidite solid-phase synthesis is a method used in RNA synthesis well known to those skilled in the art. Unless otherwise specified, all nucleoside monomers used are commercially available.
[0241] (1-a) Solid phase phosphoramidite method
[0242] The siRNA sequences listed in Table 2 were obtained by solid phase phosphoramidite method.
[0243] For the justice chain, a universal solid phase carrier (UnyLinker TM loaded HL SolidSupports, Kinovate Life Sciences, Inc.) starts the cycle, and connects the nucleoside monomers one by one from the 3'-5' direction according to the sequence of nucleotide arrangement. Each conn...
Example Embodiment
[0283] Experimental Example 1 Detection of the inhibitory efficiency of siRNA on CTGF mRNA expression in Hela cells.
[0284] Use Lipofectamine TM In 2000, the siRNAs obtained in Preparation Example 1 were respectively transfected into Hela cells, and the final concentration of siRNA was 50 nM. Each siRNA was transfected into 3 replicate wells. Cells without any siRNA treatment served as blank control.
[0285] The expression of CTGF mRNA in Hela cells transfected with each siRNA was detected by Quantitative Real-Time PCR. The specific steps are: After culturing the transfected cells for 24 hours, use Trizol (Thermo Fisher) to extract the total RNA from the cells according to the standard operating procedures for total RNA extraction; take 1 μg of total RNA, and use the reverse transcription kit (Promega) , Item No. A3500) Reverse transcription to obtain cDNA according to the operating method of its manual. Use 2×Ultra SYBR Mixture (with ROX) (Beijing Kangwei Century Biotechnol...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap